CDER's Newest "Super-Office" Focuses On Drug Security
This article was originally published in The Pink Sheet Daily
Executive Summary
Reorganization of FDA Center for Drug Evaluation and Research's Office of Compliance includes a new entity dedicated to supply chain integrity, imports and recalls.